ArticleMolecular biotechnology2026
A New Anatomical Nano Interbody Fusion Device for Elderly Patients Undergoing Anterior Discectomy and Interbody Fusion.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the perioperative outcomes of a novel anatomical nano-cage in elderly patients undergoing anterior discectomy and interbody fusion, with special attention to its outcomes on clinical symptoms, interbody fusion stability, and surgery-related complications.
methodstwenty-four cases of elderly surgical patients were divided into control group 1 (Cntrl 1), control group 2 (Cntrl 2), control group 3 (Cntrl 3), and the Experimental group (Exptl), 6 cases in each group. The polyetheretherketone interbody fusion cage was used in Cntrl 1 group, the titanium alloy interbody fusion cage was used in Cntrl 2 group, the spine minimally invasive interbody fusion cage was used in Cntrl 3 group, and the nano-hydroxyapatite/polyamide 66 (nHA/PA66) interbody fusion cage was used in Exptl group. All patients received anterior discectomy and interbody fusion, and received perioperative nursing intervention. The management of postoperative complications and patient observation indexes were recorded in detail.
resultsThe fusion of the fusion cage was better in the Exptl group than in the Cntrl group after surgery. At 2 weeks, 3 months, and 6 months after operation, the intervertebral space height of Exptl group was higher than that of Cntrl group (P < 0.05). Visual analogue scale (VAS) was lower in Exptl group than in Cntrl group (P < 0.05). At 2 weeks and 3 months after surgery, Japanese Orthopaedic Association (JOA) scores were higher in Exptl group than in Cntrl group (P < 0.05). Complications occurred more frequently in the Exptl group than in the Cntrl group.
conclusionthe novel anatomical nano-interbody fusion markedly improved the stability, the effective implementation of perioperative care reduced the incidence of complications, and the postoperative follow-up suggested that the successful application of interbody fusion cage had a positive impact on the overall rehabilitation of patients.
Indexed as
Identifiers
40169476What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.